Craft

Optomed

Stock Price

€3.8

2024-10-29

Market Capitalization

€74 M

2024-10-29

Revenue

€15 M

FY, 2024

Optomed Summary

Company Summary

Overview
Optomed is a medical technology company specializing in portable eye screening solutions. It operates in two business segments: Devices and Software. The Devices segment develops, commercializes, and manufactures handled fundus cameras suitable for screening eye diseases, such as diabetic retinopathy, glaucoma, and AMD (age-related macular degeneration). The Software segment develops and commercializes screening software for diabetic retinopathy and cancer screening for health organizations.
Type
Public
Status
Active
Founded
2004
HQ
Oulu, FI | view all locations
Website
https://www.optomed.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Petri Salonen, Director

    • Sakari Knuutti

      Sakari Knuutti, Chief Legal Officer

      LocationsView all

      6 locations detected

      • Oulu, Pohjois-Pohjanmaa HQ

        Finland

        Yrttipellontie 1

      • Pleasanton, CA

        United States

        1153 Wenig Ct

      • Boston, MA

        United States

      • Shanghai Shi

        China

        1325 Huaihai Road, Huai Hai Lu Xi Duan, Xuhui Qu

      • Espoo

        Finland

        Keilaranta 16b

      • Tampere

        Finland

        Hatanpään valtatie 24

      Optomed Financials

      Summary Financials

      Revenue (FY, 2024)
      €15.0M
      Gross profit (FY, 2024)
      €9.7M
      Net income (FY, 2024)
      (€5.5M)
      Cash (FY, 2024)
      €10.5M
      EBIT (FY, 2024)
      (€6.0M)
      Enterprise value
      $67.3M

      Footer menu